Open Journal of Immunology

Vol.2 No.3(2012), Paper ID 22534, 13 pages

DOI:10.4236/oji.2012.23011

 

Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA)

 

Pauline T. Lukey, Hayley C. Perry, Shuying Yang, Simon Parry, Marion C. Dickson, Virginia H. Norris, Paul G. Russell, Marie Watissée, Inmaculada Rioja, Keith P. Ray, Scott Crowe, Michael Binks

 

GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK
GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, UK

 

Copyright © 2012 Pauline T. Lukey, Hayley C. Perry, Shuying Yang, Simon Parry, Marion C. Dickson, Virginia H. Norris, Paul G. Russell, Marie Watissée, Inmaculada Rioja, Keith P. Ray, Scott Crowe, Michael Binks et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Lukey, P. , Perry, H. , Yang, S. , Parry, S. , Dickson, M. , Norris, V. , Russell, P. , Watissée, M. , Rioja, I. , Ray, K. , Crowe, S. and Binks, M. (2012) Single doses of p38 MAP kinase inhibitors or prednisolone affect CRP and IL-6 in patients with active Rheumatoid Arthritis (RA). Open Journal of Immunology, 2, 85-97. doi: 10.4236/oji.2012.23011.

Copyright © 2026 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.